Brady Huggett is features editor at The Transmitter, where he writes and edits features and long-form projects. He is also the creator and host of the “Synaptic” podcast. Before joining The Transmitter in 2022, he served as business editor at Nature Biotechnology, and prior to that was the managing editor of BioWorld.
Brady Huggett
Features editor
The Transmitter
From this contributor
Releasing the Hydra with Rafael Yuste
By
Brady Huggett, Shaena Montanari
4 April 2025 | 10 min read
Timothy Ryan on his pivotal switch from studying particle physics to decoding synaptic transmission
By
Brady Huggett
1 October 2024 | 70 min listen
Biosensors and being fearless with Lin Tian
By
Brady Huggett
1 September 2024 | 62 min listen
Education
- M.A. in creative writing, The New School
- M.A. in journalism, University of North Carolina at Chapel Hill
- B.S. in biology from Wake Forest University in Winston-Salem, North Carolina
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
By
Chand Chandrasekaran
20 April 2026 | 6 min read
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read